Research Gist
Curcumin, the main active compound in turmeric, influences several biological pathways linked to mood, including inflammation, oxidative stress and the body's stress-hormone system. This randomized, double-blind, placebo-controlled study tested curcumin in 56 adults diagnosed with major depressive disorder. Participants took either 500 mg of curcumin twice daily or a placebo for eight weeks, with mood assessed using a standardized self-rated questionnaire. During the first four weeks, both groups improved. From week four to week eight, however, curcumin was significantly more effective than placebo in improving overall mood-related symptoms. There was also a trend towards lower trait anxiety, though it did not reach statistical significance. The benefit was greater in a subgroup with a particular symptom pattern. The authors described the results as partial support and called for larger, longer studies.
Key Learnings
- Between weeks 4 and 8, curcumin improved mood-related symptoms more than placebo.
- Both groups improved in the first four weeks, showing why longer use matters.
- There was a trend towards lower anxiety, though it was not statistically significant.
- Curcumin acts on inflammation, oxidative stress and stress-hormone pathways linked to mood.
- The authors described this as partial support — larger, longer trials at different doses are needed.